PHASE-II TRIAL OF CARACEMIDE (NSC-253272) IN ADVANCED UNRESECTABLE NON-SMALL-CELL BRONCHOGENIC-CARCINOMA - AN ILLINOIS CANCER COUNCIL STUDY

被引：7
|
作者：
LAD, T
SCHOR, J
MULLANE, M
CARROLL, R
CHERNICOFF, D
BLOUGH, R
WEIDNER, L
机构：
[1] UNIV ILLINOIS,DEPT MED,MED ONCOL SECT,CHICAGO,IL 60680
[2] W SIDE VET AFFAIRS MED CTR,CHICAGO,IL
[3] CHICAGO OSTEOPATH MED CTR,CHICAGO,IL
来源：
INVESTIGATIONAL NEW DRUGS | 1992年 / 10卷 / 01期
关键词：
PHASE-II; CARACEMIDE; NON-SMALL-CELL LUNG CANCER;
D O I：
10.1007/BF01275475
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：27 / 28
页数：2
相关论文
共 50 条
  • [31] PHASE-II TRIAL OF CIS-DIAMMINEDICHLOROPLATINUM (CDDP) IN PATIENTS WITH NON-SMALL CELL BRONCHOGENIC-CARCINOMA (NSCBC) NOT EXPOSED TO PRIOR CHEMOTHERAPY
    BERENZWEIG, M
    VOGL, SE
    KAPLAN, BH
    LANHAM, R
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 457 - 457
  • [32] PHASE-II TRIAL OF DAILY ORAL ETOPOSIDE IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER
    SAXMAN, S
    LOEHRER, PJ
    LOGIE, K
    STEPHENS, D
    WORKMAN, F
    SCULLIN, D
    EINHORN, LH
    ANSARI, R
    INVESTIGATIONAL NEW DRUGS, 1991, 9 (03) : 253 - 256
  • [33] FAILURE OF THE PERIOPERATIVE PCV NEOADJUVANT POLYCHEMOTHERAPY IN RESECTABLE BRONCHOGENIC NON-SMALL-CELL CARCINOMA - RESULTS FROM A RANDOMIZED PHASE-II TRIAL
    DAUTZENBERG, B
    BENICHOU, J
    ALLARD, P
    LEBEAU, B
    COETMEUR, D
    BRECHOT, JM
    POSTAL, MJ
    CHASTANG, C
    CANCER, 1990, 65 (11) : 2435 - 2441
  • [34] PHASE-II STUDY OF CARBOPLATIN, CISPLATIN, AND VINDESINE IN ADVANCED NON-SMALL-CELL LUNG-CANCER
    SAITO, H
    SHIMOKATA, K
    SAKA, H
    YAMAMOTO, M
    OGASAWARA, T
    NOMURA, F
    SAKAI, S
    IWATA, M
    MURATE, T
    MIYACHI, T
    NAKASHIMA, K
    SAITO, H
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1993, 33 (02) : 154 - 156
  • [35] PHASE-II STUDY OF TAXOL IN PATIENTS WITH UNTREATED ADVANCED NON-SMALL-CELL LUNG-CANCER
    MURPHY, WK
    FOSSELLA, FV
    WINN, RJ
    SHIN, DM
    HYNES, HE
    GROSS, HM
    DAVILLA, E
    LEIMERT, J
    DHINGRA, H
    RABER, MN
    KRAKOFF, IH
    HONG, WK
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) : 384 - 388
  • [36] BISANTRENE IN ADVANCED, HORMONE-RESISTANT CARCINOMA OF THE PROSTATE - AN ILLINOIS-CANCER-COUNCIL PHASE-II STUDY
    VOGELZANG, NJ
    LANZOTTI, VJ
    MUNTEAN, B
    BLOUGH, RR
    INVESTIGATIONAL NEW DRUGS, 1990, 8 (03) : 313 - 315
  • [37] LONIDAMINE IN NON-SMALL-CELL LUNG-CANCER - A PHASE-II STUDY
    CONTU, A
    OLMEO, NA
    PANI, P
    DERIU, A
    ORTU, S
    PAGA, C
    TUMORI, 1991, 77 (01) : 52 - 55
  • [38] PHASE-II TRIAL OF 6-THIOGUANINE IN ADVANCED RENAL-CELL CARCINOMA - AN ILLINOIS CANCER CENTER STUDY
    SHEVRIN, DH
    KILTON, LJ
    LAD, TE
    MULLANE, M
    ESPARAZ, B
    KNOP, R
    EGNER, J
    JOHNSON, P
    BLOUGH, R
    FRENCH, S
    BENSON, AB
    INVESTIGATIONAL NEW DRUGS, 1994, 12 (04) : 345 - 346
  • [39] PHASE-II STUDY OF RECOMBINANT BETA INTERFERON IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CARCINOMA
    ETTINGER, DS
    HARWOOD, K
    MEDICAL AND PEDIATRIC ONCOLOGY, 1988, 16 (01): : 30 - 32
  • [40] PHASE-II TRIAL OF THORACIC IRRADIATION, HEXAMETHYLMELAMINE, ADRIAMYCIN, AND METHOTREXATE IN REGIONAL STAGE-III NON-SMALL CELL BRONCHOGENIC-CARCINOMA (NSCBC)
    BONOMI, P
    STOLBACH, L
    PATEL, V
    SALAZAR, O
    CREECH, R
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 520 - 520
12345